The publication is reproduced in full below:
IN RECOGNITION OF HOSSAM MAKSOUD, PHARMD
______
HON. CAROLYN B. MALONEY
of new york
in the house of representatives
Thursday, December 9, 2021
Mrs. CAROLYN B. MALONEY of New York. Madam Speaker, I rise to pay tribute to Dr. Hossam Maksoud for his outstanding career and dedication to creating accessible health services. For over twenty-five years, Dr. Maksoud has been at the forefront of providing affordable medication and healthcare.
When Dr. Maksoud received his pharmaceutical degree in 1990 from St. John's University's School of Pharmacy, he already had an established family business and chain of pharmacies in Egypt. Dr. Maksoud used this entrepreneurial experience in the United States to establish Maksoud Pharm, Inc in 1993.
Maksoud Pharm grew into a chain of independent retail pharmacies in the New York tristate area. With the revenues generated from Maksoud Pharm, Dr. Maksoud was able to launch his long-term care pharmacy company, Community Care Rx.
Dr. Maksoud currently serves as Chief Executive Officer of Community Care Rx. As a long-term care pharmacy, the company serves Adult & Pediatric Residential Programs, Assisted Living Facilities, Hospital Discharge Programs, HIV Programs, Hospital and Nursing Home Discharges and Skilled Nursing Facilities. Community Care Rx has a specific focus on nonprofit organizations that serve individuals unable to care for themselves.
Dr. Maksoud's goal is to address pharmaceutical drug shortages, working with lists provided by the Food and Drug Administration (FDA). Over the years, Dr. Maksoud created additional healthcare companies to confront shortage concerns, such as Community Care Specialty Pharmacy, which is URAC and ACHC accredited, to address the difficulty in obtaining specialty disease state medications for patients. Dr. Maksoud also created Community Care Consulting, which reviews patients' medication charts in order to reduce patient and facility financial burdens.
In 2017, Dr. Maksoud once again launched an initiative to address the drug shortage problem. With four partners, he created Dawah Pharmaceuticals, Inc., a drug manufacturing company. Dawah Pharmaceuticals aims to provide affordable medication to the market by producing generic versions of otherwise widely inaccessible medication. One of these generics is currently under review by the FDA and has a projected release in the second quarter of 2022. In partnership with Oakrum Pharma, Dawah Pharmaceuticals will market the medication through wholesale distribution across the United States, to the benefit of institutions such as hospitals and clinics.
Dr. Maksoud is a board member of the Egyptian African Business Association (EABA) and is an active participant in many long-term care and nonprofit associations in the tristate area, such as IAC, ESAAL, NYAEMP, NYSACRA, HCANJ, and NJACP. Additionally, Dr. Maksoud, along with his family, established The Maksoud Foundation, which assists the elderly in obtaining medication they cannot afford.
As a dual citizen of Egypt and the United States with extensive experience living and working in multiple countries, Dr. Maksoud brings a unique perspective to his work. His global experience has demonstrated to him the importance and the value of diversity and community philanthropy.
Madam Speaker, I ask my colleagues to join me in recognizing Dr. Hossam Maksoud for his community service, his generosity, and especially his commitment to providing affordable medication and increasing access to quality healthcare.
____________________
SOURCE: Congressional Record Vol. 167, No. 213
The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
House Representatives' salaries are historically higher than the median US income.
Alerts Sign-up